Showing results (291-300 of 428) with videos related to
Sort By:
Pageof 43
Acta Neurochirurgica. Supplement|August 15, 2012
Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2)R Loch Macdonald, Randall T Higashida, Emanuela Keller, et al.Journal of Vascular Surgery|January 11, 2026
General versus Non-General Anesthesia in Transfemoral and Transradial Carotid Artery StentingHaris Kamal, Meer E Hassan, Farhan Siddiq, et al.The Lancet. Neurology|June 7, 2011
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)R Loch Macdonald, Randall T Higashida, Emanuela Keller, et al.Stroke|March 10, 2012
Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coilingR Loch Macdonald, Randall T Higashida, Emanuela Keller, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 21, 2009
Evaluation of a revised Glasgow Coma Score scale in predicting long-term outcome of poor grade aneurysmal subarachnoid hemorrhage patientsRobert M Starke, Ricardo J Komotar, Grace H Kim, et al.Neurocritical Care|June 19, 2007
External ventricular drainage response in poor grade aneurysmal subarachnoid hemorrhage: effect on preoperative grading and prognosisEvan R Ransom, J Mocco, Ricardo J Komotar, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 2, 2013
Impact of premorbid hypertension on haemorrhage severity and aneurysm rebleeding risk after subarachnoid haemorrhageGian Marco De Marchis, Hector Lantigua, J Michael Schmidt, et al.Neurocritical Care|October 12, 2012
Effectiveness and safety of nicardipine and labetalol infusion for blood pressure management in patients with intracerebral and subarachnoid hemorrhageSantiago Ortega-Gutierrez, Jiz Thomas, Andres Reccius, et al.Journal of Neurosurgery|August 10, 2024
REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhageStephan A Mayer, Nicolas Bruder, Giuseppe Citerio, et al.Current Neurology and Neuroscience Reports|July 15, 2024
Critical Care of Spinal Cord InjurySabrina L Zeller, Alan Stein, Ilya Frid, et al.Pageof 43